Same as what LC said last time before they release the data cut which show a CR and multiple SD and PR early in Ph1 with patients on low dosage, that they are seeing it's working on human as seen in preclinical studies but they also need to tick off durability and not just release an announcement in 6 months it's working and then 18 months later tell the market the opposite.
RAC Price at posting:
$1.14 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)